Louisa C. Boyd

Louisa C. Boyd

Auto-generated profile, based on publicly available information

Louisa C. Boyd

University of Virginia, Charlottesville, VA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2017 in Blood Advances
Verified
Journal Article
Open access
PDF file
JEJuvianee Ibrahim Estrada-Veras
Juvianee Ibrahim Estrada-Veras
KOKevin J. O’brien
Kevin J. O’brien
LBLouisa C. Boyd
Louisa C. Boyd
RDRahul H. Dave
Rahul H. Dave
BDBenjamin H Durham
Benjamin H Durham
WGWilliam A. Gahl
William A. Gahl
Key Points: ECD varies in terms of age of onset, clinical presentation, manifestations, organ involvement, disease severity, and survival. ECD is a neoplasm and should be adopted by the field of hematology-oncology following the World Health Organization reclassification.

29 March 2020 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
LBLouisa C. Boyd
Louisa C. Boyd
KOKevin J. O’brien
Kevin J. O’brien
NONeval Ozkaya
Neval Ozkaya
TLTanya Lehky
Tanya Lehky
AMAvner Meoded
Avner Meoded
RDRahul H. Dave
Rahul H. Dave
Objective: To characterize the spectrum of neurologic involvement in Erdheim–Chester Disease (ECD), a treatable inflammatory neoplasm of histiocytes.Methods: Sixty‐two patients with ECD were prospectively enrolled in a natural history study that facilitated collection of clinical, imaging, laboratory, neurophysiologic, and pathologic data.Results: Ninety‐four percent of the patients had neurologic abnormalities on examination or imaging, and 22% had neurologic symptoms as the initial presentation of ECD. The most common neurologic findings were cognitive impairment, peripheral neuropathy, pyramidal tract signs, cranial nerve involvement, and cerebellar ataxia. Imaging revealed atrophy and demyelination along with focal lesions that were located throughout the nervous system, dura, and extra‐axial structures. The BRAF V600E variant correlated with cerebral atrophy. Brain pathology revealed lipid‐laden, phagocytic macrophages (histiocytes) accompanied by demyelination and axonal degeneration.Interpretation: In patients with ECD, neurologic morbidity is common and contributes significantly to disability. Since neurologic symptoms can be the presenting feature of ECD and, given the mean delay in ECD diagnosis is 4.2 years, it is critical that neurologists consider of ECD and other histiocytosis in patients with inflammatory, infectious, or neoplastic‐appearing white matter. Furthermore, given the broad spectrum of neurologic involvement, neurologists have an important role in a team of specialists treating ECD patients.

16 January 2019 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
LBL. C. Boyd
L. C. Boyd
GBG. A. Bond
G. A. Bond
AJAlireza Hamidian Jahromi
Alireza Hamidian Jahromi
SKS. D. Kozusko
S. D. Kozusko
ZKZinon Kokkalis
Zinon Kokkalis
PKP. Konofaos
P. Konofaos

28 August 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SHSara G. Haroutunian
Sara G. Haroutunian
KOKevin O'Brien
Kevin O'Brien
JEJuvianee Ibrahim Estrada-Veras
Juvianee Ibrahim Estrada-Veras
JYJianhua Yao
Jianhua Yao
LBLouisa C. Boyd
Louisa C. Boyd
BGBernadette Gochuico
Bernadette Gochuico
Limited information is available regarding interstitial lung disease (ILD) in Erdheim–Chester disease (ECD), a rare multisystemic non-Langerhans cell histiocytosis. Sixty-two biopsy-confirmed ECD patients were divided into those with no ILD (19.5%), minimal ILD (32%), mild ILD (29%), and moderate/severe ILD (19.5%), based on computed tomography (CT) findings. Dyspnea affected at least half of the patients with mild or moderate/severe ILD. Diffusion capacity was significantly reduced in ECD patients with minimal ILD. Disease severity was inversely correlated with pulmonary function measurements; no correlation with BRAF V600E mutation status was seen. Reticulations and ground-glass opacities were the predominant findings on CT images. Automated CT scores were significantly higher in patients with moderate/severe ILD, compared to those in other groups. Immunostaining of lung biopsies was consistent with ECD. Histopathology findings included subpleural and septal fibrosis, with areas of interspersed normal lung, diffuse interstitial fibrosis, histiocytes with foamy cytoplasm embedded in fibrosis, lymphoid aggregates, and focal type II alveolar cell hyperplasia. In conclusion, ILD of varying severity may affect a high proportion of ECD patients. Histopathology features of ILD in ECD can mimic interstitial fibrosis patterns observed in idiopathic ILD.

1 April 2021 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
AJAlireza Hamidian Jahromi
Alireza Hamidian Jahromi
LBLouisa C. Boyd
Louisa C. Boyd
LSLoren S Schechter
Loren S Schechter

31 October 2018 in Journal of Plastic Surgery and Hand Surgery
Verified
Journal Article
Closed access
SKSteven D. Kozusko
Steven D. Kozusko
AKAlexander J. Kaminsky
Alexander J. Kaminsky
LBLouisa C. Boyd
Louisa C. Boyd
PKPetros Konofaos
Petros Konofaos
Research has shown that temporary innervation by a sensory neuron can provide trophic support to a denervated muscle and stave off muscular atrophy until motor neuron transfer is viable. This so called 'sensory protection' allows for improved outcomes when motor reinnervation able to occur. The theoretical benefit of sensory neurotization is hypothesized to maintain tissue architecture of the end organ due to tropic effects of stimulation. While the literature supports direct motor neurotization from 2 to 4 months post-injury, patient factors including the location of the injury and loss of nerve can preclude this therapeutic window. When direct neurotization is not possible, or there is a long distance to traverse for reinnervation, sensory neurotization may be beneficial. The theorized trophic stimulation enabling end organ architectural maintenance provided by sensory neurotization has been shown to allow for delayed direct motor neurotization without the irreversible sequelae of prolonged denervation. This is a review of the pathogenesis of nerve injury and a literature review of sensory neurotization. An analytical search of the literature in PubMed was performed in order to find articles pertinent to the topic of sensory neurotization, including experimental data from both animal models and case reports in humans.